Home › Cancer (all types) › NCT05802069
MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)
Medical College of Wisconsin Master Predict (Profile Related Evidence Determining Individualized Cancer)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Subjects aged 18 years and older who were previously or are currently receiving care for a cancer-related condition at MCW/FH.
About the study
The study is an observational trial for patients undergoing cancer-related interventions and therapy at Medical College of Wisconsin Cancer Center. Projects under this protocol will use patient data that will be collected both retrospectively and prospectively. It will also enable prospective sample collection for specific cancer-related studies.
Sponsor: Sameem M. Abedin, MD · Participants: 10,000 · Started: Dec 19, 2022
Contact the study team
- Kristina Jacobs · Phone: 414-955-3643
- Medical College of Wisconsin Cancer Center Clinical Trials Office · Phone: 866-680-0505
Official record on ClinicalTrials.gov — NCT05802069
Locations in the U.S.
| Wisconsin | Froedtert Hospital and the Medical College of Wisconsin, Milwaukee |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.